HomeFile

File

View Category
Antiplatelet

TCT 2019 | AUGUSTUS ACS: Apixaban vs. Warfarin and Aspirin vs. Placebo in AF and ACS

Courtesy of SBHCI. The safety and efficacy of antithrombotic and antiplatelet treatments in patients with atrial fibrillation...
solaci -
Learn More
Coronary disease

TCT 2019 | IDEAL-LM: Bioabsorbable Polymer DES vs. Permanent Polymer DES for Left Main Stenosis

Courtesy of SBHCI. This study showed that using the everolimus eluting stent with bioabsorbable polymer Synergy followed by...
solaci -
Learn More
Coronary disease

TCT 2019 | Onyx ONE: Durable Polymer vs. Polymer-Free Stent with Only One Month of Dual Antiplatelet Therapy

Courtesy of the SBHCI. This is the first randomized study comparing a durable-polymer drug-eluting stent (zotarolimus-eluting stent Onyx)...
solaci -
Learn More
Antiplatelet

TCT 2019 | TWILIGHT: Minimal DAPT in High Bleeding Risk Patients

Courtesy of the SBHCI. Monotherapy with a P2Y12 inhibitor after a minimum period (3 months) of dual antiplatelet...
solaci -
Learn More
Structural heart disease

TAVR and Pacemakers, New Strategies

Courtesy of Dr. Carlos Fava. TAVR has been shown beneficial and is constantly being advanced onto lower risk...
solaci -
Learn More
Other

Should Interventional Cardiologists Be Involved in Acute Stroke?

According to this single-site study, published in J Am Coll Cardiol Intv., interventional cardiologists can safely conduct...
solaci -
Learn More
Chronic Ischemic cardiopathy

Best Conduits and Best Surgeons for the Best Outcome

Myocardial revascularization surgery is still one of the most effective treatment strategies against coronary disease. One of...
solaci -
Learn More
Coronary disease

Do Polymers Play any Role in Drug Eluting Stents

The fact that polymers can degrade after drug release seems interesting, more so when there appears to...
solaci -
Learn More